SI-BONE Inc SIBN

Morningstar Rating
$17.56 +0.14 (0.80%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

SIBN is trading at a LOCK|kFpm^> premium.
Price
$17.56
Fair Value
LOCK|.@$$N!JY
Uncertainty
LOCK|hL
1-Star Price
LOCK|.DxM&$pq
5-Star Price
LOCK|.x?zjD?
Economic Moat
LOCK|>Xn
Capital Allocation

Trading Information

Previous Close Price
$17.42
Day Range
$16.8717.76
52-Week Range
$11.4821.89
Bid/Ask
$17.55 / $20.00
Shares Outstanding
44.35M
Market Cap
$778.77M
Volume/Avg
421,147 / 681,639

Key Statistics

Price/Earnings (Normalized)
77.78
Price/Sales
3.64
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Total Yield

Company Profile

SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Core
Total Number of Employees
376

Valuation

Metric
SIBN
Price/Earnings (Normalized)
77.78
Price/Book Value
4.27
Price/Sales
3.64
Price/Cash Flow
47.04
Price/Earnings
SIBN

Financial Strength

Metric
SIBN
Quick Ratio
8.20
Current Ratio
9.99
Interest Coverage
−7.81
Quick Ratio
SIBN

Profitability

Metric
SIBN
Return on Assets (Normalized)
4.20%
Return on Equity (Normalized)
5.69%
Return on Invested Capital (Normalized)
3.12%
Return on Assets
SIBN

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
LOCK|g@z^%NLOCK|zjc%m$164B
Stryker Corp
SYK
LOCK|m^nFfQKqLOCK|@?$126B
Medtronic PLC
MDT
LOCK|cqdTqy%LOCK|?<wzJ$107B
Boston Scientific Corp
BSX
LOCK|SH$^&qLOCK|&>KL$67B
Edwards Lifesciences Corp
EW
LOCK|$#!VmflSLOCK|??qQ$53B
GE HealthCare Technologies Inc Common Stock
GEHC
LOCK|k&#M@pHLOCK|^s$29B
DexCom Inc
DXCM
LOCK|>nqlbN@LOCK|l!%$$29B
Koninklijke Philips NV ADR
PHG
LOCK|%%>LOCK|FN?$27B
Steris PLC
STE
LOCK|R@$Y?h&LOCK|PNnb%$21B
Zimmer Biomet Holdings Inc
ZBH
LOCK|L#sw^rSLOCK|F>$18B

Sponsor Center